首页> ClinicoEconomics and outcomes research : CEOR> Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study.

Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yazed,Alruthia

第一单位： Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.;Saudi Society of Pharmacoeconomics and Outcomes Research (PEOR), Riyadh, Saudi Arabia.

作者： Yazed,Alruthia ^[1] ; Horiyah,Alhajri ^[2] ; Omar A,Almohammed ^[2] ; Bander,Balkhi ^[2] ; Mai F,Alsaqa'aby ^[3] ; Mohammed A,Almuqbil ^[4] ; Hana A,Al-Abdulkarim ^[5] ; Abdulaali R,Almutairi ^[6]

作者单位： Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.;Saudi Society of Pharmacoeconomics and Outcomes Research (PEOR), Riyadh, Saudi Arabia. ^[1] Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. ^[2] Saudi Society of Pharmacoeconomics and Outcomes Research (PEOR), Riyadh, Saudi Arabia. ^[3] College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.;King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard, Riyadh, Saudi Arabia.;Division of Pediatric Neurology, Department of Pediatrics, King Abdullah Specialist Children's Hospital (KASCH), National Guard Health Affairs (NGHA), Riyadh, Saudi Arabia. ^[4] King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. ^[5] Graduate School, Alfaisal University, Riyadh, Saudi Arabia. ^[6]

关键词 MCDA simple scoring Saudi Arabia biosimilars generic drugs multicriteria decision analysis off-patent pharmaceuticals value-based purchasing

DOI 10.2147/CEOR.S568722

PMID 41527573

发布时间 2026-03-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交